Search products Close products search
Argene® Respiratory range

Argene® Respiratory range

A range of real-time PCR kits for accurate simultaneous detection of infectious agents involved in respiratory diseases.


ARGENE Respiratory menu

What could be easier? The ARGENE Respiratory range of real-time PCR kits is your solution for detection of more than 35 respiratory pathogens involved in respiratory illness, thanks to its full menu:

ARGENE® Respiratory advantages

Acute Respiratory Infections (ARI) account for an estimated 75% of all acute morbidities in industrialized countries and continue to be the leading cause of acute illness worldwide. The most serious and potentially life-threatening pneumopathies occur mainly in young children, the elderly, and immunocompromised or weakened individuals (such as those with chronic disease, cancer, or in intensive care units). The vast majority of respiratory illnesses are caused by bacteria and viruses. Since symptomatologies are similar, appropriate diagnostic testing is essential to identifying infectious agents.

Optimized detection of infectious agents is necessary to ensure optimal patient management and toprevent the spread of infection.

  • Modular multiplex solution
    • Adopt a targeted diagnostic strategy with an “à la carte” menu
    • Choose which pathogens to test depending on the season
    • Allow the diagnosis of co-infections
  • Sensitive and reproducible
    • Reliable measurement of infectious agents involved in respiratory diseases
    • All controls included (positive and negative control, cell control)
  • Standardized
    • Uniform protocol for DNA & RNA targets
    • Parallel processing with the pathogens detected with the ARGENE® Respiratory range.
    • Harmonized test profiles for multiple assays in one run
  • Flexible
    • Validated for use with various respiratory samples types
    • Compatible with automated sample preparation systems such as NUCLISENS® easyMAG®and EMAG®, as well as user-friendly assay setup techniques such as ESTREAM® liquid handling system
    • Qualified with the major real-time PCR platforms

A complete kit with all you need

ARGENE® Respiratory kits are ready-to-use molecular kits for the detection of pathogens by real-time PCR after viral DNA & RNA extraction. This 5’ nuclease-based Taqman technology amplifies and simultaneously detects a specific region of the pathogen genome.

  • Cell control to validate the sample quality for some kits
  • Negative and Pathogen-specific Positive controls
  • Includes all necessary reagents optimized to detect pathogens for in vitro diagnostic use

Straightforward procedure

Using ARGENE® Respiratory range of assays is straightforward and simple. Just add the extracted DNA or RNA sample to the ready-to-use PCR master mix chosen and start the reaction on the appropriate Real-Time PCR thermocycler, following optimized cycling program described in the “Instructions For Use”.
BIOMERIEUX, the blue logo, ARGENE®, R-GENE®, EMAG® and NUCLISENS® easyMAG® are used, pending and/or registered trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies. Any other name or trademark is the property of its respective owner.

Please consult your local bioMérieux representative for product availability in your country


Fast facts on Respiratory Pathogens

What are Respiratory Pathogens?

The vast majority of respiratory illnesses are caused by viruses and bacteria. In both children and adults, acute respiratory infections (ARI) are most frequently due to infections with Influenza A and B viruses, Parainfluenza viruses 1, 2 and 3, Respiratory Syncytial Virus (RSV A and B), Adenoviruses and Rhinoviruses. Others pathogens such as Coronaviruses, Bocaviruses, Enteroviruses, Parainfluenza 4, human Metapneumovirus, Mycoplasma pneumoniaChlamydia pneumoniae, Legionella pneumophila, Bordetella pertussis and Bordetella parapertussis also infect the respiratory tract and can cause various diseases from mild self-limiting upper respiratory infections to potentially threatening pneumonia.

Who is most at risk?

Anyone can become infected and ill with these respiratory pathogens. However, young children, the elderly, immunocompromised or weakened individuals (including those with chronic disease, cancer, or in intensive care) are most likely to suffer serious and potentially life-threatening pneumopathies.

What are the benefits of Respiratory pathogens molecular testing?

Clinical symptoms for different respiratory illnesses are similar so in vitro diagnostic molecular methods are necessary to determine the causative agents. Early, rapid and specific detection of the virus or bacteria involved using real-time PCR methods is essential to provide patient-tailored therapy for better outcomes. An accurate diagnosis will also help to control outbreaks, reduce potential antibiotic resistance and facilitate a more rapid patient recovery.